INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.46 USD
+0.01 (0.69%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $1.49 +0.03 (2.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 30% (175 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 2.02 | 9.99 |
Current Quarter Estimate | NA | 5.14 | 63.00 |
Year Ago Quarter Estimate | -12.48 | 1.41 | 52.25 |
Next Quarter Estimate | NA | 4.69 | 66.00 |
Next Year Estimate | 0.35 | 26.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 80.41 | 7.20 | 15.67 |
Next Year | 128.00 | 16.70 | 11.34 |
Last 5 Years | NA | 9.60 | 8.10 |
Next 5 Years | NA | 13.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.99 |
Price/Book (MRQ) | 0.62 | 1.96 |
Price/Cash Flow (MRFY) | NA | 13.01 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -287.16% | 9.61% |
Return on Equity (TTM) | -172.56% | 9.01% |
Debt to Equity (MRQ) | NA | 33.80 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.